Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-25-081631
Filing Date
2025-08-22
Accepted
2025-08-22 08:00:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 7420
  Complete submission text file 0001104659-25-081631.txt   9323
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-60689 | Film No.: 251242232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087
Business Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087 610-254-2999
Meridian Venture Partners II GP, L.P. (Filed by) CIK: 0001580170 (see all company filings)

EIN.: 233030799 | State of Incorp.: DE | Fiscal Year End: 1213
Type: SCHEDULE 13D/A